Human Papillomavirus (HPV) Entry Inhibitors
Publisher
Springer Singapore
Reference100 articles.
1. Aksoy P, Gottschalk EY, Meneses PI (2017) HPV entry into cells. Mutat Res Rev Mutat Res 772:13–22. https://doi.org/10.1016/j.mrrev.2016.09.004
2. Andersen JH, Jenssen H, Gutteberg TJ (2003) Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res 58(3):209–215. https://doi.org/10.1016/S0166-3542(02)00214-0
3. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG (2000) The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 74(24):11636–11641. https://doi.org/10.1128/Jvi.74.24.11636-11641.2000
4. Baleja JD, Cherry JJ, Liu Z, Gao H, Nicklaus MC, Voigt JH, Chen JJ, Androphy EJ (2006) Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Res 72(1):49–59. https://doi.org/10.1016/j.antiviral.2006.03.014
5. Beadle JR, Valiaeva N, Yang G, Yu JH, Broker TR, Aldern KA, Harden EA, Keith KA, Prichard MN, Hartman T, Buckheit RW Jr, Chow LT, Hostetler KY (2016) Synthesis and antiviral evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a potent inhibitor of transient HPV DNA amplification. J Med Chem 59(23):10470–10478. https://doi.org/10.1021/acs.jmedchem.6b00659